imatinib mesylate has been researched along with Mouth Ulcer in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chawla, R; Tripathy, K | 1 |
Hayakawa, K; Komatsu, T; Tanimoto, T; Tsuda, K | 1 |
Basso, FG; Boer, CC; Cintra, ML; Corrêa, ME; da Silva Santos, P; de Magalhães, MH; de Souza, CA; Torrezan, M | 1 |
Harn, L; Najera, JE | 1 |
de Vries, RA; Mattijssen, V; van der Heijden, AJ; van der Reijden, BA; Verstappen, MC; Wahab, PJ | 1 |
5 other study(ies) available for imatinib mesylate and Mouth Ulcer
Article | Year |
---|---|
Panuveitis simulating ocular Behçet's in cases of chronic myelogenous leukaemia in remission.
Topics: Adult; Antineoplastic Agents; Behcet Syndrome; Diagnosis, Differential; Humans; Imatinib Mesylate; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Maintenance Chemotherapy; Male; Oral Ulcer; Panuveitis; Retinal Detachment; Steroids | 2017 |
Oral mucosal manifestations of chronic eosinophilic leukaemia with FIP1L1-PDGFRα.
Topics: Antineoplastic Agents; Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; Leukemia; Male; Middle Aged; mRNA Cleavage and Polyadenylation Factors; Oncogene Proteins, Fusion; Oral Ulcer; Receptor, Platelet-Derived Growth Factor alpha | 2016 |
Skin and oral lesions associated to imatinib mesylate therapy.
Topics: Aged, 80 and over; Antineoplastic Agents; Benzamides; Dose-Response Relationship, Drug; Drug Eruptions; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Oral Ulcer; Piperazines; Protein Kinase Inhibitors; Pyrimidines | 2009 |
Chronic eosinophilic leukemia presenting with mouth and penile ulcers.
Topics: Adult; Antineoplastic Agents; Benzamides; Bone Marrow Examination; Chromosome Deletion; Chromosome Disorders; Chromosomes, Human, Pair 4; Diagnosis, Differential; Eosinophils; Gene Fusion; Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; Leukocyte Count; Male; mRNA Cleavage and Polyadenylation Factors; Oral Ulcer; Penile Diseases; Piperazines; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Ulcer | 2012 |
[A man with oral ulcers caused by hypereosinophilic syndrome and a good response to the tyrosine-kinase inhibitor imatinib].
Topics: Benzamides; Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; Male; Middle Aged; mRNA Cleavage and Polyadenylation Factors; Oncogene Proteins, Fusion; Oral Ulcer; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha | 2006 |